Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Innoviva (INVA) Return on Sales (2016 - 2025)

Historic Return on Sales for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to 0.83%.

  • Innoviva's Return on Sales rose 8200.0% to 0.83% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.46%, marking a year-over-year increase of 4800.0%. This contributed to the annual value of 0.03% for FY2024, which is 5500.0% down from last year.
  • Latest data reveals that Innoviva reported Return on Sales of 0.83% as of Q3 2025, which was up 8200.0% from 0.64% recorded in Q2 2025.
  • In the past 5 years, Innoviva's Return on Sales registered a high of 102.9% during Q1 2021, and its lowest value of 94.89% during Q1 2025.
  • Moreover, its 5-year median value for Return on Sales was 1.05% (2021), whereas its average is 10.83%.
  • Examining YoY changes over the last 5 years, Innoviva's Return on Sales showed a top increase of 1019000bps in 2021 and a maximum decrease of -1549800bps in 2021.
  • Over the past 5 years, Innoviva's Return on Sales (Quarter) stood at 6.12% in 2021, then tumbled by -61bps to 9.83% in 2022, then surged by 56bps to 4.3% in 2023, then crashed by -98bps to 8.53% in 2024, then surged by 110bps to 0.83% in 2025.
  • Its Return on Sales stands at 0.83% for Q3 2025, versus 0.64% for Q2 2025 and 94.89% for Q1 2025.